Independent Director · UroGen Pharma Ltd. (URGN)

Chair, Compliance Committee

James A. Robinson, Jr — UroGen Pharma Director Compensation (2025)

Fiscal year 2025 director compensation for James A. Robinson, Jr at UroGen Pharma Ltd.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 30, 2026 (DEF 14A). Open the filing on EDGAR.

Free

Get James A. Robinson, Jr’s full pay file as a PDF — free

More than this page: up to 10 years of James’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track James A. Robinson, Jr and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

UroGen Pharma Director Compensation Table · all 2 fiscal years held
In US dollars, as UroGen Pharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$58,478$156,000$168,743$0$383,221
FY2022—————

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: UroGen Pharma Ltd. DEF 14A filed April 30, 2026, accession 0001437749-26-014237, and prior-year filings. Open the filing on EDGAR.

How this page was built: the UroGen Pharma Ltd. filed document, accession 0001437749-26-014237. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2026.

Get the UroGen Pharma Board Governance Report

$383,221 James A. Robinson, Jr, FY2025 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 30, 2026 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2025

UroGen Pharma pays directors a $45,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Nominating/Governance · Compliance (Chair)

The rest of the UroGen Pharma board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Arie Belldegrun, M.DChair of the Board$537,486
Cynthia M. ButittaIndependent Director$389,743
Daniel G. WildmanIndependent Director$396,265
Elizabeth BarrettDirector—
Leana S. Wen, M.D., M.ScIndependent Director$392,243
Stuart Holden, M.DIndependent Director$382,243

The full UroGen Pharma compensation record

free company brief

This page is one director within UroGen Pharma's record. The company brief lists every named executive and director, each linking to their own page.

Peer companies

named in the UroGen Pharma proxy · each links to its own free brief

Order URGN

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report